Cryoport, Inc. (FRA:CKX)

Market Cap	396.67M
Revenue (ttm)	207.79M
Net Income (ttm)	53.92M
Shares Out	n/a
EPS (ttm)	1.08
PE Ratio	7.36
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	5
Open	8.05
Previous Close	8.10
Day's Range	8.05 - 8.05
52-Week Range	4.14 - 9.15
Beta	n/a
RSI	56.74
Earnings Date	Mar 6, 2026

About Cryoport

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company’s Life Sciences Services segment provides temperature-controlled logistics and cryogenic biostorage within the life science industry. Its Life Sciences Products segment offers cryogenic freezers, cryogenic dewars, and accessories within the life science industry through direct sales or a distribution network. The company’s products include Cryoport Express Shippers; Cryoport ELITE Shi...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1999
• Employees: 1,105
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: CKX

Financial Performance

In 2024, Cryoport's revenue was $228.39 million, a decrease of -2.09% compared to the previous year's $233.26 million. Losses were -$122.76 million, 14.1% more than in 2023.

Financial numbers in USD